Resources Contact Us Home
Human prostate cell lines in cancer treatment

Image Number 17 for United States Patent #8097244.

Combinations of cell lines are provided for allogeneic immunotherapy agents in the treatment of cancer. Cancer vaccines generally have been limited to the use of cells that contain at least some tumor specific antigens ("TSAs") and/or tumor associated antigens ("TAAs") having shared identity with antigens in a targeted tumor. In such cases, tumor cells often are utilized as a starting point on the premise that only tumor cells will contain TSAs or TAAs or relevance, and the tissue origins of the cells are matched to the tumor site in patients. A primary aspect of the invention is the use of immortalised normal, non-malignant cells, in combination with primary and/or metastatic tumor cells, as the basis of an allogeneic cell cancer vaccine. Normal cells do not posses TSAs or relevant concentrations of TAAs and hence it is surprising that normal cells are effective as anti-cancer vaccines when administered in combination with primary and/or metastatic tumor cells. More surprisingly, a three way combination of cells obtained from metastasized cells, non metastasized tumor and cells from a normal cell line provided good therapy. For prostate cancer, for example, a vaccine may be based on one or a combination of different immortalized normal cell lines derived from the prostate according to parameters described herein. The cell lines may be lethally irradiated with, for example, gamma irradiation at 50-300 Gy to ensure that they are replication incompetent prior to use.

  Recently Added Patents
Polyolefin and composition for pipe systems and sheets
Artificial engine sound control unit, approaching vehicle audible system, and electric vehicle having them
Performing a cyclic redundancy checksum operation responsive to a user-level instruction
Encoding digital content based on models for predicting similarity between exemplars
Feature management of a communication device
Protection circuit, substrate for electro-optical device, electro-optical device, electrophoretic display device, electronic apparatus, and manufacturing method of electro-optical device
Non-volatile memory array and device using erase markers
  Randomly Featured Patents
Thick film varistor
Thermally insulated composite flexible hose
Process for the preparation of alginate capsules, apparatus for producing said capsules and cosmetic compositions containing said capsules
Locking hinge design
Thiazolidinedione derivatives for the treatment of diabetes and other diseases
Adjusting polymer characteristics through process control
Pair of eyeglass temples
Method for measuring channel characteristics with the internet control message protocol
Cylinder lock and key combination
Support material for image-recording processes